Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | COF | GS |
|---|---|---|
| Price | $195.84 | $921.29 |
| Change today | ▼ 0.13% | ▼ 1.61% |
| Market cap | $120.14B | $268.25B |
| Return, 3 months | -2.0% | -14.0% |
| Return, year to date | -18.2% | +6.3% |
| Return, 1 year | -11.3% | +18.5% |
| P/E (TTM) | 10.4 | 14.2 |
| P/B | 1.1 | 2.4 |
| P/E percentile vs own 5y | 49th | 51st |
| Dividend yield | 1.53% | 1.85% |
| Revenue growth (YoY, latest qtr) | +26.9% | +39.5% |
| Net profit growth (YoY) | +170.6% | +78.0% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 16.4% | 30.3% |
| Return on equity | 9.1% | 18.3% |
| Analyst target vs. price | +32.2% | +30.6% |
| Analyst buy share | 89% | 46% |
| RSI (14) | 33 | 36 |
| 30-day volatility | 23.8% | 27.6% |
| Max drawdown, 1 year | -31.5% | -19.4% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.